a number of special permit claims of antiarrhythmic drugs Kela compensation have expired, tell Mediuutiset.
Huch Heart and lung centres in the rhythm of cardiology, chief physician Pekka Raatikainen illuminates the situation.
Medicines importers have raised, for example, mexiletine, quinidine and propafenonin prices up to ten - or a hundred-fold, and the Pharmaceuticals pricing board have this set for those new to the wholesale prices and the Reel-substitutability , Raatikainen told mediuutisten it.
Now, out of their own pocket can pay up to 500 euros a month, when previously the drugs were cheap.
the Drugs are no longer even generate a price ceiling, because there is not substitutability.
These medicines are used to treat life-threatening arrhythmias, and there is often no alternative medicine.